Chiesi Farmaceutici completes acquisition of Amryt Pharma

Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.

Calibre Chemicals takes over R&D activities of Tina Life Sciences

Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.

Virpax reports on progress of Envelta

Envelta is the company’s non-opioid pain product candidate for acute and chronic pain

Inflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, says GlobalData

FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop

AnaBios acquires Cell Systems to expand human cell portfolio for drug discovery

LogiPharma launches Asian focused summit, coming to Singapore in June 2023

The summit encompasses multiple verticals, spanning from pharmaceuticals, biotech, life sciences, and the Healthcare sector to ensure an unbiased and comprehensive view on the future of the function.

India showcases achievements in health sector in run up to 2nd G20 Health Working Group Meeting

Successes under Ayushman Bharat Digital Health Mission and Pradhan Mantri National Dialysis Programme highlighted

SK Capital completes acquisition of Apotex

Dozee Raises $6 million to bolster its ambition of ‘HarBedDozeeBed’

Dozee plans to further tap over 2,000 hospitals in more than 100 districts

Biocon awarded Silver Medal by EcoVadis for sustainability accomplishments

For the year 2022, Biocon bettered its score in all the four EcoVadis themes – Environment (70), Labor & Human Rights (70), Ethics (60), and Sustainable Procurement (60)